Table 1.
Variable | Respondents (n = 1190) |
Target population (n = 5053) |
p-value** | ||
---|---|---|---|---|---|
% | n | % | n | ||
Variables associated with the respondent pharmacist | |||||
Professional status | 0.858 | ||||
B.Sc. Pharmacist (Staff pharmacist) | 70 | 833 | 72 | 3654 | |
M.Sc. Pharmacist (Staff pharmacist) | 18 | 217 | 16 | 815 | |
Pharmacy owner | 12 | 140 | 12 | 584 | |
Total | 100 | 1190 | 100 | 5053 | |
Specialization of the respondent* | <0.001 | ||||
Asthma | 25 | 272 | 14 | 706 | |
Diabetes | 21 | 230 | 13 | 680 | |
Cardiovascular diseases | 20 | 221 | 12 | 613 | |
Participation in continuing education in SC | |||||
In-house training | 48 | 568 | na | na | |
Continuing education (CE) | 25 | 302 | na | na | |
In-house training by a drug company | 40 | 477 | na | na | |
CE by a drug company | 33 | 398 | na | na | |
Not participated | 20 | 229 | na | na | |
Variables associated with the respondent's working place | |||||
Location by province | 0.790 | ||||
Southern Finland | 39 | 459 | 41 | 2087 | |
Western Finland | 33 | 392 | 35 | 1773 | |
Eastern Finland | 15 | 174 | 12 | 604 | |
Northern Finland | 13 | 157 | 12 | 589 | |
Total | 100 | 1182 | 100 | 5053 | |
Annual prescription volume | 0.161 | ||||
Less than 40 000 | 21 | 252 | 16 | 782 | |
40 000-80 000 | 38 | 452 | 34 | 1751 | |
80 001 or more | 41 | 475 | 50 | 2520 | |
Total | 100 | 1179 | 100 | 5053 | |
Ownership | 0.295 | ||||
Privately owned | 94 | 1108 | 91 | 4589 | |
University owned | 6 | 75 | 9 | 464 | |
Total | 100 | 1183 | 100 | 5053 |
* Based on the professional programs run by the AFP since late 1990 s to assure community pharmacies' contribution to the national public health goals. Information available on pharmacists working in privately owned community pharmacies (missing data from the two university owned pharmacies covering about 11% of the total prescription volume).
** Counted between the of respondents and the target population in relation to the background variable
na = not available